The therapeutic effect of highly malignant triple negative breast cancer (TNBC) is negatively
affected by the formation of tumor cell resistant clone and the severe toxicity of …

There is urgency for the development of nanomaterials that can meet emerging biomedical
needs. Magnetic nanoparticles (MNPs) offer high magnetic moments and surface‐area‐to …

Triple-negative breast cancer (TNBC) cells are deficient in estrogen, progesterone and
ERBB2 receptor expression, presenting a particularly challenging therapeutic target due to …

New achievements in the realm of nanoscience and innovative techniques of nanomedicine
have moved micro/nanoparticles (MNPs) to the point of becoming actually useful for …

Magnetic nanoparticles (MNPs) represent an advanced tool in the medical field because
they can be modified according to biomedical approaches and guided by an external …

Metal nanoparticles (NPs) may have the potential to overcome problems related to
conventional chemotherapy. Metal NPs reported to play a beneficial and powerful role in …

In a report from 2008, The International Agency for Research on Cancer predicted a tripled
cancer incidence from 1975, projecting a possible 13-17 million cancer deaths worldwide by …

Cancer is a global epidemic and is considered a leading cause of death. Various cancer
treatments such as chemotherapy, surgery, and radiotherapy are available for the cure but …

Magnetic nanoparticles have been widely investigated for their great potential as mediators
of heat for localised hyperthermia therapy. Nanocarriers have also attracted increasing …

Recently superparamagnetic iron oxide nanoparticles (SPIONs) have been extensively used
in cancer therapy and diagnosis (theranostics) via magnetic targeting, magnetic resonance …